PortfoliosLab logoPortfoliosLab logo
OZEM vs. CNCR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

OZEM vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roundhill Glp-1 & Weight Loss ETF (OZEM) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


OZEM

1D
-0.73%
1M
-4.02%
YTD
-11.95%
6M
-5.58%
1Y
21.16%
3Y*
5Y*
10Y*

CNCR

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

OZEM vs. CNCR - Yearly Performance Comparison


OZEM vs. CNCR - Sectors Allocation Comparison


Sectors
OZEM
CNCR

Healthcare

100.0%
96.6%

Financial Services

0.1%
3.3%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

OZEM
100.0%
CNCR
96.6%

Financial Services

OZEM
0.1%
CNCR
3.3%

Basic Materials

OZEM

-

CNCR

-

Communication Services

OZEM

-

CNCR

-

Consumer Cyclical

OZEM

-

CNCR

-

Consumer Defensive

OZEM

-

CNCR

-

Energy

OZEM

-

CNCR

-

Industrials

OZEM

-

CNCR

-

Real Estate

OZEM

-

CNCR

-

Technology

OZEM

-

CNCR

-

Utilities

OZEM

-

CNCR

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OZEM vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OZEM
OZEM Risk / Return Rank: 2323
Overall Rank
OZEM Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
OZEM Sortino Ratio Rank: 2525
Sortino Ratio Rank
OZEM Omega Ratio Rank: 2424
Omega Ratio Rank
OZEM Calmar Ratio Rank: 2424
Calmar Ratio Rank
OZEM Martin Ratio Rank: 2020
Martin Ratio Rank

CNCR
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OZEM vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roundhill Glp-1 & Weight Loss ETF (OZEM) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OZEMCNCRDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.16

Calmar ratioReturn relative to maximum drawdown

1.11

Martin ratioReturn relative to average drawdown

2.30

OZEM vs. CNCR - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


OZEMCNCRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.87

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

Drawdowns

OZEM vs. CNCR - Drawdown Comparison

The maximum OZEM drawdown since its inception was -28.65%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for OZEM and CNCR.


Loading charts...

Drawdown Indicators


OZEMCNCRDifference

Max Drawdown

Largest peak-to-trough decline

-28.65%

0.00%

-28.65%

Max Drawdown (1Y)

Largest decline over 1 year

-19.16%

Current Drawdown

Current decline from peak

-18.74%

0.00%

-18.74%

Average Drawdown

Average peak-to-trough decline

-8.90%

0.00%

-8.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.22%

Volatility

OZEM vs. CNCR - Volatility Comparison


Loading charts...

Volatility by Period


OZEMCNCRDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.67%

Volatility (6M)

Calculated over the trailing 6-month period

17.15%

Volatility (1Y)

Calculated over the trailing 1-year period

24.46%

0.00%

+24.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.04%

0.00%

+25.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.04%

0.00%

+25.04%

OZEM vs. CNCR - Expense Ratio Comparison

OZEM has a 0.59% expense ratio, which is lower than CNCR's 0.79% expense ratio.


Dividends

OZEM vs. CNCR - Dividend Comparison

OZEM's dividend yield for the trailing twelve months is around 1.36%, while CNCR has not paid dividends to shareholders.


PositionTTM20252024
CNCR
Loncar Cancer Immunotherapy ETF
0.00%0.00%0.00%
OZEM
Roundhill Glp-1 & Weight Loss ETF
1.36%1.20%0.22%

Frequently Asked Questions


On fees, OZEM is cheaper at 0.59% per year. The better choice depends on whether you care most about return, fees, risk, or income.

OZEM is cheaper with a 0.59% expense ratio, compared with 0.79% for CNCR.

OZEM has the higher dividend yield at 1.36%, compared with 0.00% for CNCR.

They also come from different issuers: Roundhill and Exchange Traded Concepts. Their fees differ too: 0.59% for OZEM and 0.79% for CNCR.

Portfolio Optimizer

Find the right allocation for OZEM and CNCR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer